Literature DB >> 9201071

Antisecretory mechanisms of peptide YY in rat distal colon.

E E Whang1, O J Hines, J R Reeve, D Grandt, J A Moser, A J Bilchik, M J Zinner, D W McFadden, S W Ashley.   

Abstract

Peptide YY (PYY) is a potent regulator of intestinal secretion. These studies investigated the role of Y1 and Y2 receptor subtypes in mediating the antisecretory effects of PYY on mucosa-submucosa preparations of rat distal colon. Addition of vasoactive intestinal peptide (VIP) to these tissues resulted in a 140 +/- 18% increase in basal short-circuit current (Isc) and the induction of Cl- secretion. VIP-stimulated increases in Isc were abolished by the addition of each of PYY, (Pro34)-PYY, a Y1 receptor-selective agonist, and PYY-(3-36), an endogenous Y2 receptor-selective ligand. However, when tissue neural transmission was blocked with tetrodotoxin, neither PYY nor its receptor subtype-selective analogs were able to inhibit VIP-stimulated increases in Isc. These results suggest that in the rat distal colon, the antisecretory actions of PYY are mediated through a combination of Y1 and Y2 receptor subtypes or through a novel receptor subtype that is unable to discriminate between (Pro34)-PYY and PYY-(3-36).

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9201071     DOI: 10.1023/a:1018869116284

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  27 in total

Review 1.  Neuropeptide Y-related peptides and their receptors--are the receptors potential therapeutic drug targets?

Authors:  C Wahlestedt; D J Reis
Journal:  Annu Rev Pharmacol Toxicol       Date:  1993       Impact factor: 13.820

2.  Peptide-YY and neuropeptide-Y inhibit vasoactive intestinal peptide-stimulated adenosine 3',5'-monophosphate production in rat small intestine: structural requirements of peptides for interacting with peptide-YY-preferring receptors.

Authors:  A L Servin; C Rouyer-Fessard; A Balasubramaniam; S Saint Pierre; M Laburthe
Journal:  Endocrinology       Date:  1989-02       Impact factor: 4.736

3.  Structural characterization of Y1 and Y2 receptors for neuropeptide Y and peptide YY by affinity cross-linking.

Authors:  S P Sheikh; J A Williams
Journal:  J Biol Chem       Date:  1990-05-15       Impact factor: 5.157

4.  Structural characterization of canine PYY.

Authors:  V E Eysselein; G A Eberlein; D Grandt; M Schaeffer; B Zehres; U Behn; D Schaefer; H Goebell; M Davis; T D Lee
Journal:  Peptides       Date:  1990 Jan-Feb       Impact factor: 3.750

5.  Peptide YY is a physiological regulator of water and electrolyte absorption in the canine small bowel in vivo.

Authors:  A J Bilchik; O J Hines; T E Adrian; D W McFadden; J J Berger; M J Zinner; S W Ashley
Journal:  Gastroenterology       Date:  1993-11       Impact factor: 22.682

6.  Two molecular forms of peptide YY (PYY) are abundant in human blood: characterization of a radioimmunoassay recognizing PYY 1-36 and PYY 3-36.

Authors:  D Grandt; M Schimiczek; C Beglinger; P Layer; H Goebell; V E Eysselein; J R Reeve
Journal:  Regul Pept       Date:  1994-05-05

7.  [Pro34]peptide YY is a Y1-selective agonist at peptide YY/neuropeptide Y receptors.

Authors:  D Grandt; F Feth; W Rascher; J R Reeve; E Schlicker; M Schimiczek; P Layer; H Goebell; V E Eysselein; M C Michel
Journal:  Eur J Pharmacol       Date:  1994-10-14       Impact factor: 4.432

8.  Inhibition of VIP-stimulated ion transport by a novel Y-receptor phenotype in rabbit distal colon.

Authors:  G H Ballantyne; J R Goldenring; F X Fleming; S Rush; J S Flint; L P Fielding; H J Binder; I M Modlin
Journal:  Am J Physiol       Date:  1993-05

9.  The effect of neuropeptide Y and peptide YY on electrogenic ion transport in rat intestinal epithelia.

Authors:  H M Cox; A W Cuthbert; R Håkanson; C Wahlestedt
Journal:  J Physiol       Date:  1988-04       Impact factor: 5.182

10.  Peptide YY abnormalities in gastrointestinal diseases.

Authors:  T E Adrian; A P Savage; A J Bacarese-Hamilton; K Wolfe; H S Besterman; S R Bloom
Journal:  Gastroenterology       Date:  1986-02       Impact factor: 22.682

View more
  7 in total

Review 1.  Inflammation in irritable bowel syndrome: Myth or new treatment target?

Authors:  Emanuele Sinagra; Giancarlo Pompei; Giovanni Tomasello; Francesco Cappello; Gaetano Cristian Morreale; Georgios Amvrosiadis; Francesca Rossi; Attilio Ignazio Lo Monte; Aroldo Gabriele Rizzo; Dario Raimondo
Journal:  World J Gastroenterol       Date:  2016-02-21       Impact factor: 5.742

2.  Endocrine cells in the ileum of patients with irritable bowel syndrome.

Authors:  Magdy El-Salhy; Odd Helge Gilja; Doris Gundersen; Jan Gunnar Hatlebakk; Trygve Hausken
Journal:  World J Gastroenterol       Date:  2014-03-07       Impact factor: 5.742

Review 3.  Is irritable bowel syndrome an organic disorder?

Authors:  Magdy El-Salhy; Doris Gundersen; Odd Helge Gilja; Jan Gunnar Hatlebakk; Trygve Hausken
Journal:  World J Gastroenterol       Date:  2014-01-14       Impact factor: 5.742

4.  Low densities of serotonin and peptide YY cells in the colon of patients with irritable bowel syndrome.

Authors:  M El-Salhy; D Gundersen; H Ostgaard; B Lomholt-Beck; J G Hatlebakk; T Hausken
Journal:  Dig Dis Sci       Date:  2011-11-05       Impact factor: 3.199

5.  Changes in the symptom pattern and the densities of large-intestinal endocrine cells following Campylobacter infection in irritable bowel syndrome: a case report.

Authors:  Magdy El-Salhy; Tarek Mazzawi; Doris Gundersen; Jan G Hatlebakk; Trygve Hausken
Journal:  BMC Res Notes       Date:  2013-09-29

6.  Dietary fiber in irritable bowel syndrome (Review).

Authors:  Magdy El-Salhy; Synne Otterasen Ystad; Tarek Mazzawi; Doris Gundersen
Journal:  Int J Mol Med       Date:  2017-07-19       Impact factor: 4.101

7.  Abnormalities in ileal stem, neurogenin 3, and enteroendocrine cells in patients with irritable bowel syndrome.

Authors:  Magdy El-Salhy; Odd Helge Gilja
Journal:  BMC Gastroenterol       Date:  2017-08-01       Impact factor: 3.067

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.